miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44

Published:2024-03 Issue:1 Volume:35 Page:102091
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Wu Shang-Gin^ORCID,Chang Tzu-Hua,Tsai Meng-Feng,Liu Yi-Nan,Huang Yen-Lin,Hsu Chia-Lang,Jheng Han-Nian,Shih Jin-Yuan^ORCID

Funder

Ministry of Health and Welfare

Ministry of Science and Technology

Ministry of Science and Technology, Taiwan

National Taiwan University Hospital Yun-Lin Branch

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference50 articles.

1. Cancer statistics, 2023;Siegel;CA A Cancer J. Clin.,2023

2. Lung cancer;Thai;Lancet,2021

3. Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles;Rossi;Expert Rev. Anticancer Ther.,2016

4. The Role of EREG/EGFR Pathway in Tumor Progression;Cheng;Int. J. Mol. Sci.,2021

5. Screening for epidermal growth factor receptor mutations in lung cancer;Rosell;N. Engl. J. Med.,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The γ-secretase catalytic subunit PSEN1, regulated by YY1, promotes lung adenocarcinoma progression via the Notch1/EGFR pathway;2024-09-04

2. ALDH1A1 as a marker for metastasis initiating cells: A mechanistic insight;Experimental Cell Research;2024-09

3. Development of red blood cell-derived extracellular particles as a biocompatible nanocarrier of microRNA-204 (REP-204) to harness anti-neuroblastoma effect;Nanomedicine: Nanotechnology, Biology and Medicine;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3